CP and aceruloplasminemia: Recombinant production of human CP would allow to exploit the power of site-directed mutagenesis to clarify the molecular bases of functional impairment of aceruloplasminemia missense mutants, and it could also provide an answer to many open questions regarding the precise details of the catalytic mechanism of CP and of its interaction with ferroportin.